drugset / Trial / NCT06608459

PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study

NCT06608459 ↗

Phase 2 Not yet recruiting 10 enrolled Filament Health Corp. University of British Columbia · collab
NaSingle-groupOpen-labelOther

Summary

The goal of this clinical trial is to learn if it is feasible to use PEX010 for the treatment of opioid use disorder in adults. The study will also assess the safety of PEX010. The main questions it aims to answer are: Can we successfully recruit participants, provide the drug and retain participants for the duration of the study? What medical problems do participants experience when taking PEX010? Participants will: Take PEX010 twice during the study Engage in cognitive behavioural therapy Visit the clinic once or twice per week for study intervention and followup visits

Timeline

Start
2024-12
Primary completion
2026-12
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject PYEX Unknown 25 mg Oral
Subject PYEX Unknown 35 mg Oral